Extrauterine Mesonephric-like Neoplasms: Expanding the Morphologic Spectrum

other OA: green public-domain-us
AI-generated summary by claude@2026-06, 2026-06-07

This study reports five extrauterine mesonephric-like proliferations with novel features, expanding their known morphologic spectrum and providing evidence for a Mullerian origin in some cases.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-07 · read from full text

This paper reports 5 cases of extrauterine mesonephric-like proliferations (4 ovarian and 1 extraovarian) describing their clinical presentation, pathology, immunohistochemistry, and molecular alterations. The authors find that these lesions can show KRAS variants (4 cases) and PIK3CA variants (3 cases), and they expand the spectrum of tumor associations, including an origin in extraovarian endometriosis and associations with high-grade serous carcinoma, mixed germ cell tumor with mature teratoma, and a borderline ovarian endometrioid tumor with mesonephric differentiation; the study notes that molecular testing helped confirm mesonephric-like lesions and relationships between components, with some cases supporting a Mullerian rather than true mesonephric origin. A key limitation is the very small, case-based nature of the series, which includes novel features not previously reported. This paper is centrally about endometriosis — it reports an extrauterine mesonephric-like adenocarcinoma arising in extraovarian endometriosis.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Mesonephric-like adenocarcinomas (MLA) are rare neoplasms arising in the uterine corpus and ovary which have been added to the recent 2020 World Health Organization Classification of Female Genital Tumors. They have similar morphology and immunophenotype and exhibit molecular aberrations similar to cervical mesonephric adenocarcinomas. It is debated as to whether they are of mesonephric or Mullerian origin. We describe the clinical, pathologic, immunohistochemical, and molecular features of 5 cases of extrauterine mesonephric-like proliferations (4 ovary, 1 extraovarian), all with novel and hitherto unreported features. These include an origin of MLA in extraovarian endometriosis, an association of ovarian MLA with high-grade serous carcinoma, mixed germ cell tumor and mature teratoma, and a borderline ovarian endometrioid tumor exhibiting mesonephric differentiation. Four of the cases exhibited a KRAS variant and 3 also a PIK3CA variant. In reporting these cases, we expand on the published tumor types associated with MLA and report for the first time a borderline tumor exhibiting mesonephric differentiation. We show the value of molecular testing in helping to confirm a mesonephric-like lesion and in determining the relationship between the different neoplastic components. We provide further evidence for a Mullerian origin, rather than a true mesonephric origin, in some of these cases. We also speculate that in the 2 cases associated with germ cell neoplasms, the MLA arose out of the germ cell tumor.
Full text 6,316 characters · extracted from oa-html · click to expand
Extrauterine mesonephric-like neoplasms : expanding the morphologic spectrum - Author - Ellen Deolet, Iteeka Arora, Jo Van Dorpe (UGent) , Joni Van der Meulen (UGent) , Sudha Desai, Nadine Van Roy (UGent) , Baljeet Kaur, Koen Van de Vijver (UGent) and W Glenn McCluggage - Organization - Abstract - Mesonephric-like adenocarcinomas (MLA) are rare neoplasms arising in the uterine corpus and ovary which have been added to the recent 2020 World Health Organization Classification of Female Genital Tumors. They have similar morphology and immunophenotype and exhibit molecular aberrations similar to cervical mesonephric adenocarcinomas. It is debated as to whether they are of mesonephric or Mullerian origin. We describe the clinical, pathologic, immunohistochemical, and molecular features of 5 cases of extrauterine mesonephric-like proliferations (4 ovary, 1 extraovarian), all with novel and hitherto unreported features. These include an origin of MLA in extraovarian endometriosis, an association of ovarian MLA with high-grade serous carcinoma, mixed germ cell tumor and mature teratoma, and a borderline ovarian endometrioid tumor exhibiting mesonephric differentiation. Four of the cases exhibited a KRAS variant and 3 also a PIK3CA variant. In reporting these cases, we expand on the published tumor types associated with MLA and report for the first time a borderline tumor exhibiting mesonephric differentiation. We show the value of molecular testing in helping to confirm a mesonephric-like lesion and in determining the relationship between the different neoplastic components. We provide further evidence for a Mullerian origin, rather than a true mesonephric origin, in some of these cases. We also speculate that in the 2 cases associated with germ cell neoplasms, the MLA arose out of the germ cell tumor. - Keywords - Ovary, mesonephric-like adenocarcinoma, extrauterine, immunohistochemistry, molecular, YOLK-SAC TUMOR, RECURRENT KRAS MUTATIONS, FEMALE GENITAL-TRACT, UTERINE CERVIX, CELL TUMOR, ADENOCARCINOMAS, CARCINOMA, BENIGN, OVERREPRESENTATION, TRISOMY-12 Downloads - (...).pdf - full text (Published version) - | - UGent only - | - | - 574.82 KB Citation Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-8714330 - MLA - Deolet, Ellen, et al. “Extrauterine Mesonephric-like Neoplasms : Expanding the Morphologic Spectrum.” AMERICAN JOURNAL OF SURGICAL PATHOLOGY, vol. 46, no. 1, 2022, pp. 124–33, doi:10.1097/PAS.0000000000001766. - APA - Deolet, E., Arora, I., Van Dorpe, J., Van der Meulen, J., Desai, S., Van Roy, N., … McCluggage, W. G. (2022). Extrauterine mesonephric-like neoplasms : expanding the morphologic spectrum. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 46(1), 124–133. https://doi.org/10.1097/PAS.0000000000001766 - Chicago author-date - Deolet, Ellen, Iteeka Arora, Jo Van Dorpe, Joni Van der Meulen, Sudha Desai, Nadine Van Roy, Baljeet Kaur, Koen Van de Vijver, and W Glenn McCluggage. 2022. “Extrauterine Mesonephric-like Neoplasms : Expanding the Morphologic Spectrum.” AMERICAN JOURNAL OF SURGICAL PATHOLOGY 46 (1): 124–33. https://doi.org/10.1097/PAS.0000000000001766. - Chicago author-date (all authors) - Deolet, Ellen, Iteeka Arora, Jo Van Dorpe, Joni Van der Meulen, Sudha Desai, Nadine Van Roy, Baljeet Kaur, Koen Van de Vijver, and W Glenn McCluggage. 2022. “Extrauterine Mesonephric-like Neoplasms : Expanding the Morphologic Spectrum.” AMERICAN JOURNAL OF SURGICAL PATHOLOGY 46 (1): 124–133. doi:10.1097/PAS.0000000000001766. - Vancouver - 1.Deolet E, Arora I, Van Dorpe J, Van der Meulen J, Desai S, Van Roy N, et al. Extrauterine mesonephric-like neoplasms : expanding the morphologic spectrum. AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2022;46(1):124–33. - IEEE - [1]E. Deolet et al., “Extrauterine mesonephric-like neoplasms : expanding the morphologic spectrum,” AMERICAN JOURNAL OF SURGICAL PATHOLOGY, vol. 46, no. 1, pp. 124–133, 2022. @article{8714330, abstract = {{Mesonephric-like adenocarcinomas (MLA) are rare neoplasms arising in the uterine corpus and ovary which have been added to the recent 2020 World Health Organization Classification of Female Genital Tumors. They have similar morphology and immunophenotype and exhibit molecular aberrations similar to cervical mesonephric adenocarcinomas. It is debated as to whether they are of mesonephric or Mullerian origin. We describe the clinical, pathologic, immunohistochemical, and molecular features of 5 cases of extrauterine mesonephric-like proliferations (4 ovary, 1 extraovarian), all with novel and hitherto unreported features. These include an origin of MLA in extraovarian endometriosis, an association of ovarian MLA with high-grade serous carcinoma, mixed germ cell tumor and mature teratoma, and a borderline ovarian endometrioid tumor exhibiting mesonephric differentiation. Four of the cases exhibited a KRAS variant and 3 also a PIK3CA variant. In reporting these cases, we expand on the published tumor types associated with MLA and report for the first time a borderline tumor exhibiting mesonephric differentiation. We show the value of molecular testing in helping to confirm a mesonephric-like lesion and in determining the relationship between the different neoplastic components. We provide further evidence for a Mullerian origin, rather than a true mesonephric origin, in some of these cases. We also speculate that in the 2 cases associated with germ cell neoplasms, the MLA arose out of the germ cell tumor.}}, author = {{Deolet, Ellen and Arora, Iteeka and Van Dorpe, Jo and Van der Meulen, Joni and Desai, Sudha and Van Roy, Nadine and Kaur, Baljeet and Van de Vijver, Koen and McCluggage, W Glenn}}, issn = {{0147-5185}}, journal = {{AMERICAN JOURNAL OF SURGICAL PATHOLOGY}}, keywords = {{Ovary,mesonephric-like adenocarcinoma,extrauterine,immunohistochemistry,molecular,YOLK-SAC TUMOR,RECURRENT KRAS MUTATIONS,FEMALE GENITAL-TRACT,UTERINE CERVIX,CELL TUMOR,ADENOCARCINOMAS,CARCINOMA,BENIGN,OVERREPRESENTATION,TRISOMY-12}}, language = {{eng}}, number = {{1}}, pages = {{124--133}}, title = {{Extrauterine mesonephric-like neoplasms : expanding the morphologic spectrum}}, url = {{http://doi.org/10.1097/PAS.0000000000001766}}, volume = {{46}}, year = {{2022}}, } - Altmetric - View in Altmetric - Web of Science - Times cited:

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

MeSH descriptors

Adenocarcinoma Mullerian Ducts Ovarian Neoplasms Peritoneal Neoplasms Wolffian Ducts Adenocarcinoma Adenocarcinoma Adenocarcinoma Adenocarcinoma Adult Aged Aged, 80 and over Biomarkers, Tumor Biomarkers, Tumor Biomarkers, Tumor Cell Differentiation Cell Proliferation Class I Phosphatidylinositol 3-Kinases Class I Phosphatidylinositol 3-Kinases Female

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-06-11T06:19:48.454388+00:00
pubmed
last seen: 2026-05-13T22:24:31.988741+00:00
unpaywall
last seen: 2026-05-14T19:30:52.867331+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine